Palatin Technologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTN and other ETFs, options, and stocks.About PTN
Palatin Technologies, Inc. is a biopharmaceutical company, which engages in the development of medicines based on molecules that modulate the activity of the melanocortin receptor system. Its primary product candidate is marketed under the Vyleesi brand, the trade name for bremelanotide, which is used for the treatment of premenopausal women with acquired, generalized, hypoactive sexual desire disorder (HSDD).
CEOCarl Spana
CEOCarl Spana
Employees29
Employees29
HeadquartersPrinceton, New Jersey
HeadquartersPrinceton, New Jersey
Founded1986
Founded1986
Employees29
Employees29
PTN Key Statistics
Market cap27.21M
Market cap27.21M
Price-Earnings ratio-1.22
Price-Earnings ratio-1.22
Dividend yield—
Dividend yield—
Average volume75.26K
Average volume75.26K
High today$16.38
High today$16.38
Low today$14.13
Low today$14.13
Open price$16.38
Open price$16.38
Volume21.35K
Volume21.35K
52 Week high$72.50
52 Week high$72.50
52 Week low$1.75
52 Week low$1.75
Stock Snapshot
The current Palatin Technologies(PTN) stock price is $15.73, with a market capitalization of 27.21M. The stock trades at a price-to-earnings (P/E) ratio of -1.22.
During the trading session on 2026-01-03, Palatin Technologies(PTN) shares reached a daily high of $16.38 and a low of $14.13. At a current price of $15.73, the stock is +11.3% higher than the low and still -3.9% under the high.
Trading volume for Palatin Technologies(PTN) stock has reached 21.35K, versus its average volume of 75.26K.
The stock's 52-week range extends from a low of $1.75 to a high of $72.50.
The stock's 52-week range extends from a low of $1.75 to a high of $72.50.
People also own
Based on the portfolios of people who own PTN. This list is generated using Robinhood data, and it’s not a recommendation.